PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Korean Journal of Schizophrenia Research10.16946/kjsr.2020.23.2.45202023245-50Treatment-Resistant Schizophrenia: Terminology and Clinical FeaturesKounseok Leehttp://kjsr.org/upload/pdf/kjsr-2020-23-2-45.pdf, http://kjsr.org/journal/view.php?doi=10.16946/kjsr.2020.23.2.45, http://kjsr.org/upload/pdf/kjsr-2020-23-2-45.pdf
Treatment–Refractory Schizophrenia10.1007/978-3-642-45257-4_122014179-193Pharmacogenetics and Treatment-Resistant SchizophreniaAdriana Foster, Peter F. Buckleyhttps://link.springer.com/content/pdf/10.1007/978-3-642-45257-4_12
Treatment–Refractory Schizophrenia10.1007/978-3-642-45257-4_82014107-120Therapeutic Brain Stimulation in Treatment-Resistant SchizophreniaPeter B. Rosenquist, Anthony O. Ahmed, W. Vaughn McCallhttps://link.springer.com/content/pdf/10.1007/978-3-642-45257-4_8
Schizophrenia Research10.1016/j.schres.2003.07.0032004662-3183-186Secretin in a patient with treatment-resistant schizophrenia and prominent autistic featuresSayed S. Alamy, L.Fredrik Jarskog, Brian B. Sheitman, Jeffrey A. Liebermanhttps://api.elsevier.com/content/article/PII:S092099640300241X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S092099640300241X?httpAccept=text/plain
Schizophrenia Research10.1016/j.schres.2023.01.0222023252294-295Psychopathology, clinical insight and cognitive insight in patients with treatment resistant schizophreniaVikas Gaur, Shubhangi Singhhttps://api.elsevier.com/content/article/PII:S0920996423000348?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0920996423000348?httpAccept=text/plain
Schizophrenia Research and Treatment10.1155/2015/532082201520151-7The Impact of Childhood Adversity on the Clinical Features of SchizophreniaRavi Philip Rajkumarhttp://downloads.hindawi.com/journals/schizort/2015/532082.pdf, http://downloads.hindawi.com/journals/schizort/2015/532082.xml, http://downloads.hindawi.com/journals/schizort/2015/532082.pdf
European Neuropsychopharmacology10.1016/s0924-977x(17)31965-x201727S1135Clinical presentation of treatment-resistant schizophrenia (TRS)J. Kanehttps://api.elsevier.com/content/article/PII:S0924977X1731965X?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0924977X1731965X?httpAccept=text/plain
Schizophrenia Research10.1016/j.schres.2018.06.0302018202217-225Clinical evaluation of functional capacity in treatment resistant schizophrenia patients: Comparison and differences with non-resistant schizophrenia patientsFelice Iasevoli, Luigi D'Ambrosio, Danilo Notar Francesco, Eugenio Razzino, Elisabetta Filomena Buonaguro, Sara Giordano, Thomas L. Patterson, Andrea de Bartolomeishttps://api.elsevier.com/content/article/PII:S0920996418303645?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0920996418303645?httpAccept=text/plain
Schizophrenia Research10.1016/j.schres.2019.07.0212019211108-110The clinical correlation and predictive value of electrophysiological variables on clinical response to clozapine in patients with treatment-resistant schizophreniaSakir Gica, Ahsen Buyukavsar, Burc Cagri Poyraz, Huseyin Gulechttps://api.elsevier.com/content/article/PII:S0920996419302993?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0920996419302993?httpAccept=text/plain
Schizophrenia Research10.1016/s0920-9964(00)90772-22000411193The study of olanzapine plus fluoxetine in treatment-resistant major depressive disorder without psychotic featuresR.C. Shelton, M. Tohen, S. Stahl, T. Jacobs, K.S. Gannon, G.D. Tollefsonhttps://api.elsevier.com/content/article/PII:S0920996400907722?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0920996400907722?httpAccept=text/plain